Ozapex (Olanzapine)

Olanzapine, the active ingredient in Ozapex, is an atypical antipsychotic presented as a tablet for oral use. It is prescribed for the management of schizophrenia and bipolar disorder in adults. GNH USA supplies Ozapex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ozapex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ozapex is an atypical antipsychotic that modulates neurotransmitter activity in several psychiatric conditions.

- Schizophrenia: helps control delusions, hallucinations and thought disorder. - Bipolar I disorder (manic episodes): reduces manic symptoms and stabilises mood. - Bipolar II disorder (depressive episodes): assists in mood stabilization when used with other agents. - Psychotic depression: alleviates depressive symptoms with psychotic features. - Schizoaffective disorder: improves both psychotic and mood components.

Side effects vary in frequency and severity and should be monitored throughout treatment.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia or new‑onset diabetes - Agranulocytosis - Seizures - Elevated liver enzymes

When prescribing Oz ​​  ​  ​  ​  ​  …  ...  … … … … … … … … … …  … … … … … … … … … … … … … … …

-        …  …  … ​  … … … ... … … … ... ... … … … …